 |
Personalizing Disease Managementcan improve the length and quality of life, while reducing the cost of managing your health. We’re developing tests and services that identify a person's inherent risk for a disease and may also characterize its biological basis, aiding selection among treatment options and monitoring treatment effectiveness. |
 |
Berkeley HeartLabprovides cardiovascular disease management through a combination of proprietary lipid testing technology, esoteric testing capability, advanced therapy guidelines and patient support services. |
 |
4myheart.com4myheart.com is our proprietary web-based personalized disease management system used by physicians and patients to manage cardiovascular disease and ensure compliance with treatment plans. |
Recent News
September 2, 2008
Celera to Webcast its Analyst and Investor Meeting on September 9, 2008
August 25, 2008
Celera Elects Peter Barton Hutt to Board of Directors
August 4, 2008
Celera Appoints Jean Amos Wilson, Ph.D., as a Vice President of Laboratory Operations at Berkeley HeartLab
